skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines donanemabQuestion & answer

donanemab · Medicine question

What is the elimination half-life of donanemab?

iatroX medicinesPublished 8 November 2026

The answer

Answer

The elimination half-life of donanemab is approximately 12.1 days.

Sources for this answer

Kisunla 350 mg concentrate for solution for infusionEli Lilly and Company Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 3Document updated 24 March 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

donanemab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

More questions about donanemab

What is the shelf life of an unopened vial of Kisunla (donanemab) 350 mg concentrate for solution for infusion?Are pharmacokinetic drug interactions expected with donanemab?Does Kisunla (donanemab) affect the ability to drive or use machines?How does donanemab help remove amyloid plaques from the brain?How is Kisunla (donanemab) administered?How much sodium does each 20 ml vial of Kisunla (donanemab) contain?

Read the donanemab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX